Adaptimmune Therapeutics PLC (NASDAQ:ADAP)
| 1.07 BATS BZX Real-Time Price As of 10:43am ET |  +0.01 / +0.94%Today’s Change | 1.01 Today|||52-Week Range 2.65 | -26.71% Year-to-Date |
Latest ADAP News | Press Releases
No recent news for Adaptimmune Therapeutics PLC.
Today’s Trading
| Previous close | 1.06 |
| Today’s open | 1.09 |
| Day’s range | 1.07 - 1.09 |
| Volume | 2,610 |
| Average volume (3 months) | 501,180 |
| Market cap | $180.2M |
Data as of 10:43am ET, 03/30/2023
Growth & Valuation
| Earnings growth (last year) | -1.10% |
| Earnings growth (this year) | -289.41% |
| Earnings growth (next 5 years) | +5.60% |
| Revenue growth (last year) | +341.28% |
| P/E ratio | NM |
| Price/Sales | 8.67 |
| Price/Book | 2.19 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| XXII22nd Century Group I... | +0.03 | +3.58% |
| LRMRLarimar Therapeutics... | -0.05 | -1.15% |
| SELBSelecta Biosciences ... | +0.05 | +3.89% |
| TCRTAlaunos Therapeutics... | +0.01 | +2.28% |
Data as of 11:01am ET, 03/30/2023
Financials
| Next reporting date | May 8, 2023 |
| EPS forecast (this quarter) | -$0.19 |
| Annual revenue (last year) | $27.1M |
| Annual profit (last year) | -$165.4M |
| Net profit margin | -609.46% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Abingdon, Oxfordshire |
Forecasts
